Reaping Infusions Llp - Company Profile

It is a textile limited liability partnership based in Delhi, Delhi, India, established in 2022.
2022 Delhi, Delhi, India Active
Last Updated:
Access Report
About Reaping Infusions Llp

Reaping Infusions Llp, a active limited liability partnership, was established on 24 February 2022 in Delhi, Delhi, India. Engaging in textile within the textile sector, it holds LLPIN: ABA-7956. Registered under ROC Roc Delhi I. It has total obligation of contribution of ₹0.50 M.

Its leadership includes Vinod Kumar (Designated Partner), Apar Chopra (Designated Partner). It holds ₹1.35 Cr open charges and no settled loans. Its latest date of accounts and solvency statement 31 March 2024. It is based at E 75, Vishwakarma Colony, Lal Kuan, M. B. Road,, Delhi, Delhi, 110044.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    ABA-7956

  • Incorporation Date

    24 February 2022

  • Total Obligation of Contribution

    ₹0.50 M

  • ROC Code

    Roc Delhi I

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.50 M
  • Company Age 4 Year, 1 Month
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 1.35 Cr
Company report

Reaping Infusions Llp

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Reaping Infusions Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Reaping Infusions Llp?
Current Designated Partners
Name Designation Appointment Date Status
Vinod Kumar Designated Partner 24 Feb 2022 Current
Apar Chopra Designated Partner 24 Feb 2022 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Reaping Infusions Llp.

Enhance accessibility to Reaping Infusions Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Reaping Infusions Llp revenue growth over time
Reaping Infusions Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Reaping Infusions Llp?

Unlock access to Reaping Infusions Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹13,500,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Icici Bank Limited : 1.35 Cr
Latest Charge Details
Date Lender Amount Status
16 Aug 2024 Icici Bank Limited ₹1.35 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Reaping Infusions Llp?

Unlock and access historical data on people associated with Reaping Infusions Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Reaping Infusions Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reaping Infusions Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Reaping Infusions Llp
Recent Activity within the Organization
  • Annual General Meeting

    The activity Reaping Infusions Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was completed.

  • Charges

    The activity A charge with Icici Bank Limited amounted to Rs. 13.50 M with Charge ID 101001288 was registered on 16 Aug 2024. was completed.

  • Statement of Assets & Liabilities

    The activity Reaping Infusions Llp has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi I. was completed.

  • Director Appointment

    The activity Vinod Kumar was appointed as a Designated Partner was appointed as a Designated Partner on 24 Feb 2022 & has been associated with this company since 4 years 1 month . was completed.

  • Director Appointment

    Progress on Apar Chopra was appointed as a Designated Partner was appointed as a Designated Partner on 24 Feb 2022 & has been associated with this company since 4 years 1 month . was documented.

  • LLP Incorporation

    Reaping Infusions Llp was registered on 24 Feb 2022 with Roc Delhi I & aged 4 years 1 month as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Reaping Infusions Llp?

The LLPIN of Reaping Infusions Llp is ABA-7956.

Where is Reaping Infusions Llp headquartered?

Reaping Infusions Llp is headquartered at E 75, Vishwakarma Colony, Lal Kuan, M. B. Road,, Delhi, Delhi, 110044.

When was Reaping Infusions Llp incorporated?

Reaping Infusions Llp was incorporated on 24 February 2022.

Who are the current directors of Reaping Infusions Llp?

The current directors of Reaping Infusions Llp are

What is the primary industry of Reaping Infusions Llp?

The primary industry of Reaping Infusions Llp is Textile.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available